4processed

Form 4 — Insider Transaction

Maze Therapeutics, Inc.(MAZE)

Filing Date

June 29, 2026

Accepted

June 29, 2026

Accession No.

0002050167-26-000016

CIK

0001842295

Insider Transactions

InsiderTitleTypeSharesPriceValueOwned AfterSecurityDate
Dandekar AtulCSBOOther7.5K$10.4233.8KCommon StockJun 29, 2026
Dandekar AtulCSBOOther7.5K$28.0226.3KCommon StockJun 29, 2026
Dandekar AtulCSBOOther7.5K$029.1KStock Option (Right to Buy)Jun 29, 2026